Understanding What Regulators Want from Your Clinical Trial to Substantiate New Claims: A Case Study
Time: 1:00 pm
day: Conference Day Two
Details:
- Exploring the hurdles that still exist in evaluating the health benefits of a product
- The global health authorities have not provided detailed instructions of on how to evaluate the develop clinical trials and evaluate the totality of evidence for claim substantiation
- Discussing the essential elements that should be embraced by clinical trials to make it eligible and desirable for and considerations for the totality of evidence for claim substantiation
